Topic Archives: DaiIchi Sankyo (DSKYF)

In his tearjerker “Sisters of Mercy,” Leonard Cohen sings, I’ve been where you’re hanging and think I can see how you’re pinned. Although I am less inclined to bash the FDA than many, it has recently let modern medical practice place many patients in an undesirable situation. What if there was a very powerful drug, […]

Comments

  • Avatar

    $ABIO An interesting marketing/research report on companies developing therapies for Atrial Fibrillation is just issu...

  • Avatar

    $PIRS (long) Thanks Dr. KSS, for filling in the missing gaps on PRS-080! Heading to work now, so not listening to ...

  • Avatar

    Heads up for anyone planning on buying or selling $PIRS in the near future: This quarter, likely in June, Pieris plan...

  • Avatar

    $PIRS (long) For the Pieris buffs here who may interested -- I just listened to Monday's presentation from Pieris CEO...

  • Avatar

    $PTLA, long, with a small bit of news: http://seekingalpha.com/pr/16652167-portola-pharmaceuticals-expands-clinical-col...

  • SoGiAm

    $PIRS to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration HT https://twitter.com/odibro/status/79124921...

  • Avatar

    I found it incredulous they would include Enoxaparin on their label. That seemed to come out of left field. Epoxaban I ...

  • Avatar

    okay, this makes sense to me. Dialysis patients are smaller group within the larger anemic population. But a large per...

  • SoGiAm

    $PTLA Portola Pharmaceuticals, Inc. Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiich...

  • SoGiAm

    AGEN, AKBA, PIRS, FLKS: Extracted from: http://www.thelifesciencesreport.com/pub/na/panelists-select-19-companies-for-t...

  • SoGiAm

    Daiichi Sankyo Co Ltd -Some informative videos including the life cycle of pharmaceutical a product: http://www.daiichi...

  • Avatar

    RIGL (Rigel Pharmaceuticals ) -- Don’t believe this has been discussed. “ …. focuses on intracellular s...

  • Avatar

    The Credit Suisse report is 81 pages of information regarding Biosimilars vs. Biologics. A number of power points that a...

  • Avatar

    Perosphere and Daiichi Sankyo ink third collaboration agreement on anticoagulant reversal drug • 1:55 PM Douglas W...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info